EMvision (ASX:EMV) share price falling despite positive results

The EMvision share price is falling lower today despite the company announcing positive results in clinical trials of its stroke technology.

| More on:
falling asx share price represented by business man wearing box on his head with a sad, crying face on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The EMvision Medical Devices Ltd (ASX: EMV) share price has opened lower this morning despite the company reporting encouraging data from its pilot clinical trial. EMvision provides imaging technology for classifying different types of strokes. Stroke treatments often require differentiation between the two basic types of stroke. This determination is essential before pursuing effective and time-critical therapies. This positive news was not sufficient to keep the EMvision share price from falling in early trade today.

Stroke causes an enormous health and economic burden throughout the world. It is the second leading cause of death and the third leading cause of disability globally. Imaging is the key to diagnosis and monitoring of acute stroke. 

In year-to-date trading, the EMvision share price has risen by 276% and has a current market capitalisation of $153 million. In addition, the company successfully completed a share placement for $6 million in July, underscoring investor interest in the technology. 

What did EMvision announce?

The results of EMvision's trial were resoundingly positive. First, the device was reportedly able to classify a stroke type (haemorrhagic or ischaemic) with an overall accuracy of between 93.3% and 96%. Second, it was able to localise targets in the correct brain quadrant with an overall accuracy of between 86.7% and 96%. 

The study enrolled and processed datasets from 30 patients with a diversity of stroke in localisation, size and severity. Moreover, the study has enabled the algorithm team to advance the hybrid 'fusion' methodology, a powerful approach to imaging. It works by extracting the target lesion and estimated location in each algorithm and applies a pixel-wise voting algorithm.

The fused image then leverages the classification algorithm. The algorithm team will continue to advance this fusion methodology in consultation with EMVision's clinical advisors. 

Why does this matter?

The rapid ability to classify stroke types and locations is valuable for time-sensitive treatment. Moreover, as noted by EMVision clinical advisor, Professor Michael O'Sullivan:

…Interesting future questions include the sensitivity of the technique for early detection of bleeding, both in the pre-hospital setting and in stroke units, where monitoring is currently limited to detection of clinical deterioration…

EMVision's CEO, Dr Ron Weinberger, commented:

These promising results, the first in stroke patients for our technology, provide a strong foundation with which to progress our development program. We are delighted by these results which indicate that we are able to discriminate and localize haemorrhagic and ischaemic strokes with an encouraging degree of accuracy under these conditions. We have exceeded our original objectives for this study. While we still have a way to go, we are well placed to develop our value proposition into a fully-fledged commercial product.

About the EMVision share price 

At the time of writing, the EMVision share price has fallen 3.17% lower to $2.75. The company's shares have recovered more than 500% from their March lows but are down nearly 13% from the 52%-week high of $3.15 reached earlier this month.

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Market up or down
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the week...

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Share Gainers

4 ASX 200 shares racing ahead of the benchmark this week

ASX investors sent these four stocks soaring 12% to 18% this week. But why?

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Dateline, DroneShield, Ora Banda, and Pilbara Minerals shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why BHP, Coronado Global, EBR Systems, and Whitehaven Coal shares are pushing higher today

These shares are ending the week on a positive note. Let's find out why.

Read more »

man thinking about whether to invest in bitcoin
Broker Notes

Why Macquarie expects this ASX 200 dividend stock to keep outperforming

Macquarie has tipped this ASX 200 dividend stock to outperform. Let’s find out why.

Read more »

a young woman looks happily at her phone in one hand with a selection of shopping bags in her other hand.
BNPL shares

Up 87% since April, why the Zip share price can keep flying higher into 2026

A leading fund manager expects more outsized gains from Zip shares ahead.

Read more »

Man in mining hat with fists raised and eyes closed looking happy and excited about the Newcrest share price
Share Market News

Why BHP and these ASX dividend stocks are buys

The mining giant and these shares have been named as buys by brokers.

Read more »